BUSINESS● LOWOct 6 · Oct 6, 2026, 3:49 PM
Eli Lilly-backed TRex Bio targets up to $133M in U.S. IPO
Seeking Alpha Tech · north america
TRex Bio, a company backed by Eli Lilly, is targeting to raise up to $133 million in a U.S. initial public offering. This financial move reflects the company's growth strategy and market aspirations.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowCocoa: why the alliance between Ivory Coast and Ghana is falteringJeune AfriqueBUSINESS12m agoHong Kong aims for share of HK$350 billion yacht industry as travel scheme launchesSouth China Morning Post